PF-06282999
Sponsors
Pfizer
Conditions
Healthy
Phase 1
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects
CompletedNCT01626976
Start: 2012-06-30End: 2013-03-31Updated: 2013-03-13
A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults
CompletedNCT01707082
Start: 2012-10-31End: 2013-05-31Updated: 2013-07-31
A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model
TerminatedNCT01965600
Start: 2014-03-31End: 2015-02-28Updated: 2016-08-02